Patent details

Basic Information

Publication number:

EP1609505

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP050187624

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of fluorinated triazoles for treating affective or attention disorders

French Title of Invention:

Utilisation de triazoles fluorés pour le traitement des troubles affectifs ou de l'attention

German Title of Invention:

Verwendung von fluorierten Triazolen zur Behandlung von affektiven Störungen oder Aufmerksamkeitsstörungen

SPC Number:

Dates

Filing date:

28/02/2000

Grant date:

11/12/2013

EP Publication Date:

11/12/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/12/2005

EP B1 Publication Date:

11/12/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/02/2015

Expiration date:

28/02/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/02/2000

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

Name:

Schmutz Markus

Address:

Switzerland (CH)

Priority

1

Priority Number:

259910

Priority Date:

01/03/1999

Priority Country:

United States (US)

2

Priority Number:

259911

Priority Date:

01/03/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 25/00;

Filing date	Document type	Number of pages